Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

被引：4

作者：

Antinori, A

Cingolani, A

Perno, CF

机构：

[1] IRCCS, Natl Inst Infect Dis, Clin Dept, I-00149 Rome, Italy

[2] Catholic Univ, Dept Infect Dis, Rome, Italy

来源：

AIDS | 2005年 / 19卷 / 15期

关键词：

D O I：

10.1097/01.aids.0000183513.29890.0b

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1691 / 1694

页数：4

共 23 条

[1]

Blackham J, 2005, AIDS, V19, P487

[2]

Ciancio BC, 2003, ANTIVIR THER, V8, P611

[3] Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations [J].

Clotet, B ;

Raffi, F ;

Cooper, D ;

Delfraissy, JF ;

Lazzarin, A ;

Moyle, G ;

Rockstroh, J ;

Soriano, V ;

Schapiro, J .

AIDS, 2004, 18 (08) :1137-1146

[4] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].

Deeks, SG ;

Wrin, T ;

Liegler, T ;

Hoh, R ;

Hayden, M ;

Barbour, JD ;

Hellmann, NS ;

Petropoulos, CJ ;

McCune, JM ;

Hellerstein, MK ;

Grant, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480

[5] Treatment of anti retroviral-drug-resistant HIV-1 infection [J].

Deeks, SG .

LANCET, 2003, 362 (9400) :2002-2011

[6] CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy [J].

Deeks, SG ;

Hoh, R ;

Grant, RM ;

Wrin, T ;

Barbour, JD ;

Narvaez, A ;

Cesar, D ;

Abe, K ;

Hanley, MB ;

Hellmann, NS ;

Petropoulos, CJ ;

McCune, JM ;

Hellerstein, MK .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03) :315-323

[7]

DeGruttola V, 2000, ANTIVIR THER, V5, P41

[8] Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure [J].

Delaugerre, C ;

Valantin, MA ;

Mouroux, M ;

Bonmarchand, M ;

Carcelain, G ;

Duvivier, C ;

Tubiana, R ;

Simon, A ;

Bricaire, F ;

Agut, H ;

Autran, B ;

Katlama, C ;

Calvez, V .

AIDS, 2001, 15 (16) :2189-2191

[9]

Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001

[10] No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients [J].

Ghosn, J ;

Wirden, M ;

Ktorza, N ;

Peytavin, G ;

Aït-Mohand, H ;

Schneider, L ;

Dominguez, S ;

Bricaire, F ;

Calvez, V ;

Costagliola, D ;

Katlama, C .

AIDS, 2005, 19 (15) :1643-1647

← 1 2 3 →